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INTRODUCTION 
Optometry, s1nce the professions 1898 conception until 1970, 
remained without pharmaceutical agents for diagnostic or thera-
peutic application. In the interim years many advances in pharma-
cology were made; antibiotics, anesthetics, and synthetic agents 
with low toxicity and short duration were developed. Beneficial 
applications for these drugs were seen by optometry and the 
profession began legislative procedures to obtain pharmaceutical 
licensure. It 1s of interest that British ophthalmic opticians 
(optometrists) have used pharmaceutical agents "for more than 
half a century. The care and discrimination 1.n the use of ophthal-
mic drugs throughout this period J.S a record of which they may 
1 be proved." 
In 1971, Rhode Islands became the first state to allow diag-
nostic pharamceutical agents (DPA's) 1n the practice of optometry. 
Within a decade, 30 states (Appendix A) had DPA legislation passed 
with two states, West Virginia and North Carolina, including 
topical therapeutic pharmaceutical agents (TPA's). 
West Virginia had TPA licensure in 1976 and Oregon had DPA 
licensure in 1975. The state laws for optometry (Appendix B) 
shows the limitations imposed on Oregon optometrists in compari-
son to West Virginia optometrists. In Oregon, the drugs are 
initially introduced therefore limiting the practice of optometry 
to treatment of refractive and binocular disorders. In compar1son, 
West Virginia law prohibits surgery or other than topical appli-
cation of pharmaceuticals in the treatment of eye disorders; 
refractive, binocular dysfunctions, and pathology (anterior seg-
ment). It is this last category that two states differ. Opto-
metrists in both states are expected to detect pathology but 
Oregon optometrists must refer for treatment while West Virginia 
optometrists are permitted to treat with~n their scope of know-
ledge or refer if warranted. 
During 1981, Oregon optometrists failed an attempt to expand 
their licensure to include topical therapeutic agents. In the 
summer of 1981, Pacific University conducted a study of continuing 
education needs relative to ocular disease diagnosis and treatment 
in Oregon. With this survey instrument I intend to compare the 
results obtained from Oregon, a state contemplating the future use 
of therapeutic agents, with West Virginia, a state presently 
using therapeutic agents. 
METHODOLOGY 
The questionnaire (Appendix C) sent to West Virginia opto-
metrists was the same distributed to Oregon optometrists with 
exception of questions three and ten. 
3. Region of Oregon in which you practice; was changed to: 
Pharmaceutical agents used in your practice. 
10. Which of the following options best represents your 
interests relative to participating incontinuing 
education in the subject area of ocular pathologic 
diagnosis and treatment; was changed to: 
Which of the following options best represents the 
method of continuing education in the subject area 
of ocular pathologic diagnosis and treatment. 
The questionnaire consisted of 125 questions, 10 on practice 
characteristics and 115 on pathologic conditions. For the 115 
on pathologic conditions, there were 7 different possible answers. 
a. I feel this condition is within the scope of optometry 
at the 1 TENTATIVE' DIAGNOSIS level only and that I 
feel NO NEED for additional education at this time. 
b. I feel this condition is within the scope of optometry 
at the 'TENTATIVE' DIAGNOSIS level only and that I AM 
INTERESTED in additional education in performing this 
task. 
c. I feel this condition is within the scope of optome.try 
at the 'DEFINITIVE' DIAGNOSIS level and that I feel NO 
NEED for additional education at this time. 
d. I feel this condition is within the scope of optometry 
at the 'DEFINITIVE' DIAGNOSIS level and that I AM 
INTERESTED in additional education in performing this 
task. 
e. I feel this condition is \vithin the scope of optometry 
at the . 'DEFINITIVE DIAGNOSIS - TREATHENT' level and that 
I feel NO NEED for additional education at this time. 
f. I feel this condition is within the scope of optometry 
at the 'DEFINITIVE DIAGNOSIS - TREATHENT' level and that 
I AH INTERESTED in additional education in performing 
this task. 
g. I fe e l this condition r:IJOULD NOT be! within the sc ope of 
optometry. 
The seven were combined for tabulation into four levels: 
1. Tentative Diagnosis 
2. Definitive Diagnosis 
3. · Definitive Diagnosis/Treatment 
4. Not Within Scope of Optometry 
The survey for West Virginia was mailed to a sample of 60 
optometrists in West Virginia. This sample consisted of the opto-
~etrists licensed and residing in West Virginia in 1980 and grad-
uating in 1970 or after. These were decided would probably produce 
the highest member of optometrists presently using therapeutics. 
The 60 surveys were mailed in early January 1982. Twenty-five 
completed returns were received by February 1, 1982. 
The Oregon survey instrument had been mailed to all optometrists 
residing in the state, 136 returned survey forms were received. 
For comparison purposes a subset of 40 optometrists, graduating 
after 1970 were tabulated separately to be used for comparison 
with the West Virginia data. 
The response rate was tabulated for the four conditions; 
Tentative Diagnosis, Definitive Diagnosis, Definitive Diagnosis/ 
Treatment, Not Within Scope of Optometry. Table I identified 
those conditions receiving two-thirds (66 percent) or greater 
response· frequency. A direct comparison between number and type 
of conditions in each level with each condition listed in decreasing 
order of frequency was compiled. 
The answers for the first ten questions regarding practice 
characteristics were compared by percentage. The four levels 
previously mentioned were total ed and percentages compared for 
the 115 pathologic ' conditions. The data wa s further compared 
using four subsets of questions; Glaucoma (45-51), Cataract 
(52-55), Conjunctivitis (69-72), and Disorders of the Visual 
System (104-106). 
Practice Characteristics 
Oregon West Virginia 
Population 
less than 5,000 17.5% 16~~ 
5,000 - 9,999 10% 29% 
10,000 - 29,999 20% 32% 
30,000 - 49,999 17.5% 8% 
50,000 - 74,999 0 8% 
75,000 - 100,000 5% 12% 
more than 100,000 30% 0 
Nature of Town 
Urban 30% 28% 
Suburban 35% 36% 
Rural 32.5% 36% 
Age 
25-29 32.5% 40% 
30-34 35% 44% 
35-39 27.5% 16% 
40-44 2.5% -
45-49 2.5% -
Practice ' 
Solo 52.5% 72% 
Partnership 32.5% 16% 
Group 12 . 5% 12% 
Number of Exams/Year 
0 - 499 22.5% 4% 
500 - 999 45% 12% 
1,000 - 1,999 25% 60% 
mor e than 2,000 7.5% 24% 
Net Income 
less than 15,000 35% 20% 
15,000 - 19,000 7.5% 12% 
20,000 - 24,999 22.5% 8% 
25,000 - 29,999 15% 4% 
30,000 - 39,999 10% 12% 
more than 40,000 12.5% 40% 
Oregon West Virginia 
·-
Continuing Ed. Attended 
less than 15 15% 16% 
16 - 30 51.5% 68% 
31 - 50 25% 12% 
more than 51 7.5% 4% 
T~]:~ e of Cont. Ed. 
Would Like 
a) 3 wk. summer 7.5% 12 % 
b) 3 wk. winter 5% 12 % 
c) weekends 35% 20% 
d) week/month x 3 20% 20% 
e) 2 evenings/ week 
X 15 32 .5% 28% 
A. Tentative Diagnosis 
Conditions grea ter than 66 percent level 1n decreasing order 
of frequency. 
West Virginia 
1) 15. Malignant Neoplasm 
2) 27. Hereditary Retinal 
Dystrophus 
Oregon 
1) 15. Malignant Neoplasm 
B. Definitive Diagnosis 
.Conditions greater than 66 percent level in decreasing order 
of frequency. 
West Virginia Oregon 
l) 99. Papilledema 1) 53. Senile Cataract 
2) 26. Degeneration of Macula 2) 54. Traumatic Cataract 
and Posterior Pole 3) 82. Ectropian 
3) 100. Optic Atrophy 4) 83. Lagophthalmos 
4) llO. Other Disorders of 5) 84. Ptosis of Eyelid Lens; Sus luxation, 
Dislocation 6) 113. Coloboma 
7) 52. Infantile, Juveni l e, 
and Presenile Cataract 
8) 81. Entropian and Trichiasis 
of Eyelid 
9) 89. Epiphoria 
10) 110. Other Disorders of 
Lens; Sus luxation, 
Dislocation 
ll) 55. Cataract Secondary to 
Ocular Disorders; 
Inflammatory, Neovascu-
larization, Degenerative 
12) 73. Pterygium 
13) 100. Optic Atrophy 
C. Definitive Diagnosis - Treatme nt 
Conditions at l e ast 66 percent level in d ecreasing order of 
frequency. 
West Virginia Oregon 
1) 69. Acute Conjunctivitis 1) 64 . Corneal Ed ema 
2) 70. Chronic Conjunctivitis 2) 68. Keratoconus 
3) 71 . Blepharoconjunctivitis 3) 69. Acute Conjunctivitis 
4) 77. Blepharitis 4) 70. Chronic Conjunctivitis 
5) 57. Superficial Keratitis 
without Conjunctivitis 
5) 71. Blepharoconjunctivitis 
6) 77. Blepharitis 
6) 
7) 
8) 
9) 
68. 
64. 
120. 
78. 
10) 45. 
11) 58. 
12) 59. 
13) 46. 
14) 79; 
Keratoconus 7) 
Corneal Edema 
Foreign Body on External 
Eye; Corneal, Conjunctival 
Sac, Lacrimal Punctum 8) 
Hordeolum and Other Deep 
Reflammation of Eyelid 9) 
Borderline Glaucoma 10) 
Types of Keratoconjuncti-
vitis; Phlyctenular, 
Limbal/Corneal, Sicca, 11) 
Exposure, Neutrophic 
Unspecified Keratocon-
junctivitis 
Open-Angle Glaucoma 
Chalazion 
12) 
13) 
15) 107. Scleritis and Epis~leritis 
16) 56. Corneal Ulcer 
17) 118. Superficial Injury qf Eye 
and Adnexa; Abrastion, 
Insect Bite 
18) 13. Diseases of Conjunctiva 
due to Viruses and Chlamy-
diae 
19) 60. Interstitial and 
Deep Keratitis 
20) 62 . Corneal Scars and Oparities 
21) 65. Changes of Corneal 
Membrane 
58 . 
57. 
56. 
Types of Keratoconjuncti-
vitis; Phlyctenular, 
Limba l/Corneal, Sicca, 
Exposure, Neutrophic 
Superficial Keratitis 
Without Conjunctivitis 
Corneal Ulcer 
118. Superficial Injury of Eye 
and Adnesca; Ahrastion, 
Insect Bite 
46. Open-Angle Glaucoma 
59 . Unspecified Keratocon-
junctivitis 
78. Horde olum and Other Deep 
Reflammation of Eyelid 
West Virginia 
22) 121. Burn Confined to Eye 
and Adnexa; Chemical 
and Thermal 
23) 38. Acute and Subacute 
Iridocylitis 
24) 48. Corticosteriod-Induced 
Glaucoma 
25) 61. Corneal Neovascularization 
26) 119. Contusion of Eye and 
Adnexa 
27) 63 . Corneal Pigmentations and 
Deposits 
28) 80. Noninfectious Dermatoses 
of Eyelid 
29) 72. Conjunctivits Due to 
Toscoplasmosis 
D. Noi Within Scope of Optometry 
No condition reached the 66 percent level. 
Oregon West Virginia 
highest frequency 24% highest frequency 17.5% 
Summary 
A. Tentative Diagnosis 
B. Definitive Diagnosis 
C. Definitive Diagnosis - Treatment 
D. Not Within Scope of Optometry 
West Virginia 
2 
4 
29 
0 
Oregon 
1 
13 
13 
0 
Definitive Not In 
Tentative Definitive Treatment Optometry 
w. VA. 524 (17.6%) 1014 (34. 2%) 1268 (42.8%) 159 (5.4%) 
OREGON 1235 (26.8%) 1949 (42.4%) 1293 (28.1%) 123 (2.6%) 
Glaucoma (45-51) 
W. VA. 51 (24.6%) 40 (19.3%) 105 (50.7%) 11 (5.3%) 
OREGON 62 (15. 7%) 101 (25.5%) 114 (28.8%) 4 (1%) 
Cataract (52-55) 
w. VA. 22 ( 23%) 47 (49%) 26 (27%) 1 ( 1. 0%) 
OREGON 27 (16.8%) 117 (73.1%) 12 (7.5%) 4 (2.5%) 
Conjunctivitis (69-72) 
W. VA. 3 (2.9%) 6 (5.8%) 94 (90.4%) 1 (.9%) 
OREGON 14 (8.7%) 31 (19.4%) 110 (68.8%) 5 (3.1%) 
Disorders of Visual Pathways (104-106) 
w. VA. 32 (41 . 0%) 23 (29.5%) 14 (17.9%) 9 (11.5%) 
OREGON 66 (55%) 49 (40.8%) 2 ( 1. 6%) 3 (2.5%) 
DEFINITIVE DIAGNOSIS AND 
DEFINITIVE DIAGNOSIS/TREATMENT 
W.Virginia 77% Difference between 
Oregon 70 .5% States 8% 
GLAUCOMA (45-51) 
W.Virginia 70% Difference between 
Oregon 54.3% States 22% 
CATARACT (52-55) 
W.Virginia 76% Difference between 
Oregon 80.6% States 6% 
CONJUNCTIVITIS (69-72) 
W.Virginia 96.2% Difference between 
Oregon 88.2 States 6% 
DISORDERS OF VISUAL PATHWAYS ( l 04-l 06) 
w. Virginia 47.4% Difference between 
Oregon 42.4 States 10% 
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DISCUSSION 
The two groups of optometrists were similar by year of graduation 
(survey design) and age. Practice characteri·stics showed West Virginia 
compared with Oregon optometrists situated in smaller communities with 
increased likelihood of solo practice. They did more examinations per 
year, with a higher gross income. The two groups attended approximately 
the same amount of continuing education and favored similar times for 
continuing education. 
· Results showed the major difference in the Definitive Diagnosis/ 
Treatment level where West Virginia had 29 conditions at the 66% to 
Oregon's 13. Similarities arise in this group with Oregon's 13 being in 
the top 17 conditions of West Virginia . The other significant difference 
was in the Definitive Diagnosis level; here Oregon had 13 conditions at 
66% of West Virginia par. 
Percentages for answers of the total 115 conditions and subsets 
of glaucoma, cataract, conjunctivitis and disorders of the visual system 
were tabulated and graphed. 
A definite higher percentage of conditions fell within Definitive 
Diagnosis/Treatment level for West Virginia in all five condition classi-
fications. Also, Oregon had a higher percentage in Definitive Diagnosis 
in all five condition classifications, as compared to West Virginia. 
These five classifications were then compared by State on a 
combined Definitive Diagnosis and Definitive Diagnosis/Treatment grouping. 
In this grouping, only glaucoma had greater than 10% difference between 
States, w1th 22% higher for West Virginia than Oregon. Cataract was the 
only combined grouping which Oregon had a higher percentage than West 
Virginia but still was under 10% (6%). 
J 
In conclusion, these States differed mainly by West Virginia's 
increased number of conditions at the treatment level. In the combined 
definitive/treatment level, only glaucoma had greater than 10% difference 
between States. 
Appendix A 
Stat es which allow optometrical pharmaceutical usage and 
data of passage. 
Rhode Island (1971) Wisconsin (1978) 
Pennsylvania (1974) Nebraska (1979) 
Tennessee (197 5) Arkansas (1979) 
Oregon (1975) South Dakota (1979) 
Maine (1975) North Dakota (1979) 
Louisiana (1975) Utah (1979) 
Delaware (1975) Nevada (1979) 
West Virginia (1976) Iowa (1979) 
California (1976) Georgia (1980) 
Wyoming (1977) Arizona (1980) 
New Mexico (1977) Washington (1981) 
Montana · (1977) Idaho (1981) 
Kansas (1977) Texas (1981) 
North Carolina (1977) Missouri (1981) 
Oklahoma (1981) 
APPENDIX B 
State Optometry Laws 
Oregon 
11Practice of optometry" means the employment of any means 
other than the use of drugs, except diagnostic agents, topically 
applied, known generally ascycloplegics, mydriatics, topical 
anesthetics, dyes such as fluorescein, and, for emergency use 
only, miotics, for the measurement or assistance of the powers or 
range of human vision or the determination of the accommodative 
and refractive states of the human eye or the scope of its func-
tions in general or the adaptation of lenses or frames for the 
aid thereof, subject to the limitations of ORS 683.040. 
11 Trial frames 11 or 11 test lenses 11 means any frame or lens used 
1n testing the eye which is not sold and not for sale to customers. 
683.030. Persons and practices not affected. This Chapter 
shall not be construed to prevent any person duly licensed to 
practice medicine and surgery from treating o~ fitting glasses 
to the human eye, nor to prohibit the sale of complete ready to 
wear eyeglasses as merchandise ' from a permanent place of busi-
ness in good faith and not in evasion of this Chapter by any 
person not holding himself out as competent to examine and pre-
scribe for the human eye. 
West Virginia 
Practice of Optometry defined. Any one or any combination of 
the following practices ahall constitute the practice of optometry: 
(a) The examination of the human eye, with or without the 
use of drugs, prescribable for the human eye, which drugs may 
be used for diagnostic or therapeutic purposes for topical appli-
cation to the anterior segment of the human eye only, and, by 
any method oth~r than surgery, to diagnose, to treat or to refer 
for consultation or treatment any abnormal condition of the human 
eye or its appendages; 
(b) The employment without the use of surgery of any instru-
ment, device, method or diagnostic or therapeutic drug for topical 
application to the anterior segment of the human eye intended 
for the purpose of investigating, examining, treating, diagnosing, 
improving or correcting any visual defect or abnormal condition 
of the human eye or its appendages; 
c) The prescribing and application or the replacement or 
duplication of lenses, prisms, contact lenses, orthoptics, vision 
training, vision rehabilitation, diagnostic or therapeutic drugs 
for topical application to the anterior segment of the human eye, 
or the furnishing or providing of any prosthetic device, or any 
other method other than surgery necessary to correct or relieve 
any defects or abnormal conditions of the human eye or its appen-
dages. 
Nothing in this section shall be construed to permit an 
optometrist to perform surgery, use drugs by injection or to use 
or prescribe any drug for other than the specific purposes 
authorized by this section. 
Dear Doctor, 
Appendix C 
Allan W. Jones 
2701 Main St. #90 
Forest Grove, OR 97116 
January 5, 1982 
I ~m writing to request your assistance in obtaining information regarding 
the educational needs for ocular pathologic diagnosis apd treatment. As part 
of my thesis requirements, I plan to study the perceived educational needs by 
optometrists in the area of therapuetic drugs. Enclosed is a copy of a survey 
distributed to Oregon optometrists by Pacific University. I intend to compare 
the results of Oregon, a state contemplating the future use of therapuetic 
drugs, with West Virginia, a state which is presently using therapuetic drugs 
by optometrists. 
Your assistance in this project will be greatly appreciated. Please com-
plete the enclosed survey form and return it withinS days in the envelope 
provided. Thank you. 
Sincerely, 
a/~ 
Allan Jone s 
cc/Dr. John Casto 
Dr. Monroe N. Farmer 
1. 
2. 
3. 
4. 
5. 
6 . 
7, 
B. 
9. 
10. 
STUDY OF CONTINUING EDUCATION NEEDS 
Population of city/tlM'l in which you practice 
0 a. · under 1,000 
0 b. 1,000 "4,999 
0 c. 5,000 " 9,999 
(mark one) . 
0 d. 
0 e. 
0 f. 
Nature of city/town in w hich you pract ice (mark one). 
0 a. urban 0 b. 
Pharmaceutical agoot.~ used in y'our IJractice !mark one) . 
0 a. 
0 b. 
0 c. 
bot h therapeutic llnd d iagnostic 
diagnost ic only 
neither d iagnostic 0 1' therapeut ic 
Your age (mark o ne) . 
0 a. 20. 24 
0 b. 25 ' 29 
0 c. 30. 34 
0 d. 35. 39 
Year graduated from o ptornauy school (mark one). 
0 a. 1975 . 80 
0 b. 1970 . 74 
0 c. 1965 . 69 
0 d. 11;60 . 64 
Nature of practice (m<Jrk one). 
0 a. self-employed/solo p ract ice 
· 0 b. self -employed/piJr·t norsh ip praclice 
0 c . self -amployod/group pract ica 
0 d. employed by federal government 
0 
Ll 
0 
0 
0 
0 
0 
0 
0 
e. 
f . 
g. 
e. 
f. 
g. 
e. 
f. 
g. 
Number of visio n ana lysis porlormt~d by you in tho past 12 
0 a. 0" 499 0 e. 
0 b. 500 . 999 0 f. 
0 c. 1,000 . 1 ,499 0 g. 
0 d. 1,500 • 1,999 
Annual Net Income in '1 98 0 (mark one). 
c a. less than 10,000 0 e. 
0 b. 10,000 . 14,999 0 f. 
0 c. 15,000 . 1!),999 0 g. 
0 d. 20,000 . 24,999 
10,000 " 19,999 
20,000 " 29,999 
30,000 • 49,999 
suburban 
40. 44 
45. 49 
50. 54 
1955 • 59 
1950 . 54 
1945 • 49 
employed by o the r optometrists 
employed in multidisciplinary group 
practice 
employed by physician 
months (mark one). 
2 ,000 • 2,499 
2 ,500 . 2,999 
3,000 . 3,499 
25,000 . 29,999 
30,000 . 34,999 
35,000 . 39,999 
0 g. 
0 h. 
0 i. 
0 c. 
0 h. 
0 i. 
0 j. 
0 h. 
0 i. 
0 j. 
0 h. 
0 i. 
0 j. 
0 h. 
0 i. 
0 j. 
0 h. 
0 i. 
0 j. 
50,000 . 74 ,999 
75,000 . 100,000 
over 100,000 
rural 
55 . 59. 
60 . 64 
65 and over 
1940 . 44 
1935 . 39 
before 1935 
t 
• 
not actively practicing 
retired 
educator 
3,500 . 3,999 
4,000 . 4,999 
5,000 and over 
40,000 . 44 ,999 
45,000 . 49,999 
50,000 ·or more 
How many cloc k hours of .P•1rf.onal attendance did you devote to continuing education during the past 12 months (mark one)? 
0 a. 0" 5 0 e, 31 . 40 0 h. 101 . 150 ~ 
0 b. 6 " 15 0 f. 41 . 50 0 i. 151 . 200 
0 c. 16 " 20 0 g. 51 . 100 0 j. more than 200 
0 d. 21 . 30 
~ich ~f the following O!Jr: ion~ bast reprec>ents the method of continuing education in the subject area of ocular pathologic 
d1agnos1s and treatment lmark one). 
0 a. an intensive two t o three we<:JI< course ·o c. 
0 b. 
duri ng t ha su rn m,, r 
an int en~i v o t.wo t o lh roe week course 
during tho winter 
0 d. 
a series of week-ends for 6 · 8 weeks 
in a row 
a week long cou rse about once each 
three months 
0 e. an evening course 1 · 2 
times each week ovor 
a 15 week period 
.. 
11.·125. Followonu is a list of ophthalmic conditions (qu ~'tlons 11 -125), tnkon from thn lntornation.11 Classification of Diso<tsos 
(IDC -9 .. CM) standArd dingno,tic code book. Plo"''" rend ov.or answer options Ia) throuah (g) and mark ono answer rolativu 
to ~-~-c~~- condition listod. Enter your answer in the space providod. 
• a. 
b. 
c. 
11. 
12. 
13. 
14. 
15. 
16. 
11. 
18. 
19. 
20. 
21. 
22. 
23. 
24. 
25. 
26. 
27. 
28. 
I feel this conditlon is within the 
scope of optometry at the 
'TENTATIVE' DIAGNOSIS level 
only and that I feel NO NEED 
for additional education at this 
time. 
I feel this condition is within the 
scope of optometry at the 
'TENTATIVE' DIAGNOSIS level 
only and that I AM INTERESTED 
in additional education in perform-
ing this task. 
I feel this condition is within the 
scope of optometry at tho 
'DEFINITIVE' DIAGNOSIS level 
and that· I feol NO NEED for 
additional education at this 'iimo. 
Herpes zoster with ophthal-
mic complications 
Trachoma 
Diseases of conjunctiva due 
to viruses and Chlamydiae ,_ 
Gonococcal infaction of eye 
Malignant neopl ,asm of eye 
Benign neoplasm of eye 
Carcinoma in situ of eyelid 
Vitamin A deficiency mani· 
fest in conjunctiva 
and cornea 
Purulent endophthalmitis 
Other endophthalmitis 
Degenerative disorders and 
conditions of globe 
Hypotony of eye 
Retained (old) intraocular 
foreign body 
Retinal detachments and 
defects 
Background retinopathy and 
retinal vascular changes 
Degeneration of macula and 
posterior pole 
Hereditary retinal dystrophies 
Other retinal disorders; 
hemorrhage, exudates, 
edema, ischemia 
d. 
e. 
f. 
29. 
30. 
31. 
32. 
33. 
34. 
35. 
36. 
37. 
38. 
39. 
40. 
41. 
42. 
43. 
I feel this condition is within the 
scope d optometry at the 
'DEFINITIVE' DIAGNOSIS level 
and that I AM INTERESTED in 
additional education in perform-
ing this task. 
I feel this condition is within tho 
scope of optometry at the 
'DEFINITIVE DIAGNOSIS • 
TREATMENT' level and that 
feel NO NEED for add itional . 
education at this time. 
I feel this condition is within the 
scope of optometry at the 
'DEFINITIVE DIAGNOSIS -
TREATMENT' level and that 
AM INTERESTED in additional 
education in performing this task. 
Focal chorioretinitis and 
focal retinochoroiditis 
Disseminated chorioretinitis 
and disseminated 
retinochoroiditis 
Unspecified forms of 
chorioretinitis and 
retinochoroiditis 
Chorioretinitis due to 
toxoplasmosis 
Chorioretinal scars; post-
inflammatory, surgical, 
traumatic 
Choroidal degenerations 
Hereditary choroidal 
dystrophies 
Choroidal hemorrhage and 
rupture 
Choroidal detachment 
Acute and subacute 
iridocylitis 
Chronic iridocyclitis 
Vascular disorders of 
iris and ciliary body 
Degenerations of iris and 
ciliary body 
Cysts of iris, ciliary body, 
and anterior ch amber 
Adhesions and disruptions 
of iris and ciliary body 
g . 
44. 
45. 
46. 
47. 
48. 
49. 
50. 
51. 
52. 
53. 
54. 
55. 
56. 
57. 
I feel this condition SHOULD NOT 
be within the scope of optometry. 
Other and unspecified dis-
orders of iris and 
ciliary body 
Borderline glaucoma 
Open-angle glaucoma 
Primary angle-closure 
glaucoma 
Corticosteroid-induced 
glaucoma 
Glaucoma associated with 
' 
congenital anomalies, 
dystrophies and 
systemic syndromes 
Glaucoma associated with 
disorders of the lens 
Glaucoma associated with 
other ocular disorders; 
inflammations, vascu-
lar, tumors, trauma 
Infantile, juvenile, and 
presenile cataract 
Senile cataract 
Traumatic cataract 
Cataract secondary to 
ocular disorders; in-
flammatory, neovas-
cularization, 
degenerative 
Corneal ulcer 
Superficial keratitis with· 
out conjunctivitis 
r-
.. 
58. Types of keratoconjunctivitis; 
phlyctenular, limbar/cor· 
noal, sicca, exposure, I 
neu rotrophic 
59. Unspec ifioo keratoconjunctivitis 
60. Interst itial and deep keratitis 
61. Corneal noovascularizntion 
62. Corneal sc<us and opacities 
63. Corneal pigmentat ions and 
' deposits 
64. Corneal edema 
-
65. Changes of corneal 
membranes 
66. Corneal degenerations 
67. Hereditary corneal dystrophies 
68. Keratoconus 
69. Acute conjunctivitis 
70. Chronic conjunctivitis 
71. Blepharoconjunct ivitis 
72. Conjunctivitis due to 
toxoplasmosis 
73. Pterygium 
74. Conjunctival degenerations 
and deposits 
75,. Conjunctival scars 
76. Conjunctiva l vascular disorders 
and cysts 
77. Blepharitis 
78. Hord eo lum and other deep 
reflammation of eyelid 
79. Chalazion 
80. Noninfectious dermatoses of 
eyelid 
81. Entropion and trichiasis of 
evolid 
82. Ectropion 
·-
83. Lagophthalmos 
84. Ptosis of eyelid 
85. Degenerative disorders of 
eyelid and periocular area 
86. Other disorders of eyelid; humor-
rhage, edema, elephantiasis, 
cysts 
is7 . Dacryoadenitis 
. -
e:a. Variou:> tl tsorder ~ of lac rimal 
gland ; dacryops. cysts. 
atruphy 
89. Epiphora 
90. Acute and unspecified inflam-
motion of lacrimal passages 
g·l, Chronic inflammation of 
lacrimal passages 
----
92. Stenosis and insufficiency of 
lacrimal passages 
9 3. Acute inflammation of orbit 
94. Chronic inflammatory dis- · 
orders of orbit 
95. Exophthalmic conditions 
96. Deformity of orbit 
97. Enophthalmos 
98. Retrobulbar foreign body 
99. Papilltldema 
100. Optic atrophy 
101. Various disorders of optic disc; 
drusen, coloboma, pseudo-
papilledema 
102. Optic neuritis 
103. Various disorders of optic 
nerve; ischemic neuropathy, 
hemorrhage in sheaths 
104. Disord>llrs of optic chiasm 
10.5. Disorders of other visual 
pathways 
106. Disorders of visual cortex 
107. Scleritis and episcleritis 
108. Other disorders of sclera; 
ectasia, staphyloma 
109. Disorders of vit reous body 
110. Other disorders of lens; 
susluxation, ·dislocation 
111 . Anomalies of pupillary 
function 
112. Buphthalmos 
113. Coloboma 
114. Congenital anomalies of 
f-- posterior segment 
115. Peripheral nervous system; 
ERG, VER, EOG 
' 
t--
. 
116. Open wound of ocular adnexa 
117. Open wound of eyeball 
118 . . Superficial injury of eye and 
adnexa; abrasion, insect 
bite 
119. Contusion of eyo and adnexa 
120. Foreign body on external eye; 
corneal, conjunctival sac, 
lacrimal punctum 
~21. · Burn confined to eye and adnexa; 
chemical and thermal 
~--------------------------~-
r22. Injury to optic nerve and 
pathways 
~--------------------------~-
123. Injury to visual cortex 
!124. Poisoning by drugs; para· 
sympathomimetics, para-
sympatholytics, sympatho· 
mimetics, sympatholytics 
125. Poisoning by eye anti-i nfectives 
and other eye drugs 
